Abstract
Bone sarcomas are rare entities in clinical oncology, in which the histological subtype and site of involvement define the natural history of the disease and in particular the appropriate treatment strategy (1). Ewing sarcoma is a chemo- and radiation-sensitive disease in which combined-modality therapy (more recently including a surgical component) is mandatory for radical management (2). Osteosarcoma survival rates have been significantly improved by adjuvant chemotherapy and extremity preservation rates by neoadjuvant chemotherapy (3). Other uncommon bone sarcomas such as malignant fibrous histiocytoma (MFH) or chondrosarcoma are considered marginally sensitive to chemotherapy or radiotherapy and the primary radical treatment modality is surgery (4,5).A universal feature in the natural history of bone sarcomas is the tendency to involve the extraosseous soft tissue and neurovascular structures once the tumor growth and infiltration acquires a certain size.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Malawer MM, Link MP, and Donaldson SS. Sarcomas of the bone. In VT De Vita, S Hellman, and SA Rosenberg (eds.) Principles and Practice of Oncology, 5th ed. Lippincott-Raven, Philadelphia, 1997, pp. 1789–1816.
Rosen G. Primary Ewing’s sarcoma: the multidisciplinary lesion, Int. J. Radiat. Oncol. Biol. Phys., 4 (1978) 527–532.
Glasser DB, Lane JM, Huvos AG, Marcove RC, and Rosen G. Survival prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience, Cancer, 69 (1992) 698–708.
McCarthy SF, Matsuao F, and Dorfman HD. Malignant fibrous histiocytoma of bone: a study of 35 cases, Hum. Path., 10 (1979) 57–70.
Marcove RC. Chondrosarcoma: diagnosis and treatment, Orthop. Clin. Nort. Am, 8 (1977) 811–819.
Cortes EP, Holland JF, Wang, JJ, et al. Amputation and Adriamicyn in primary osteosarcoma, N. Engl. J. Med., 291 (1974) 998–1000.
Eilber FR, Eckhardt J, and Morton DL. Advances in the treatment of sarcomas of the extremity. Current status of limb salvage, Cancer, 54 (1984) 2695–2701.
Calvo FA, Antos M, and Brady LW. Intraoperative Radiotherapy. Clinical experiences and results, Springer Verlag, Heidelberg, 1992.
Martinez A, Goffinet DR, Donaldson SS, et al. Intra-arterial infusion of radiosesnitizer (BUdR) combined with hypofractionated irradiation and chemotherapy for primary treatment of osteogenic sarcoma, Int. J. Radiat. Oncol. Biol. Phys., 2 (1980) 123–128.
Tefft M, Razek A, Perez C, et al. Local control and survival related to radiation dose and colume and to chemotherapy in non metastatic Ewing’ s sarcoma of the pelvic bones, Int. J. Radiat. Oncol. Biol. Phys., 4 (1978) 367–372.
Krochak R, Harwood AR, Cummings BJ, et al. Results of radical radiation for chondrosarcoma of bone, Radiother. Oncol., 1 (1983) 109–115.
Calvo FA, Ortíz De Urbina D, Sierrasesumaga L, Abuchaibe O, Azinovic I, Antillon F, Santos M, and Caiïadell J. Intraoperative radiotherapy in the multidisciplinary treatment of bone sarcomas in children and adolescents, Med. Pediatr. Oncol., 19 (1991) 478–485.
Barbieri E, Emiliani E, Zini G, Mancini A, Toni A, et al. Combined therapy of localised Ewing’s sarcoma of bone: analysis of results in 100 patients, Int. J. Radiat. Oncol. Biol. Phys., 19 (1990) 1165–1170.
Dunst J, Jürgens H, Sauer R, Pape H, Paulussen M, Winkelmann W, and Riibe CH. Radiation therapy in Ewing’s sarcoma: an update of the CESS 86 trial, Int. J. Radiat. Oncol. Biol. Phys., 32 (1995) 919–930.
Halperin EC, Kun LX, Constantine LS, and Tarbell NJ. Pediatric Radiation Oncology, Raven Press, New York, 1989.
Brown AP, Fixen JA, and Plowman PN. Local control of Ewing’ s sarcoma: an analysis of 67 patients, Br. J. Radiol., 60 (1987) 261–268.
Tepper J, Glaubiguer D, Lichter A, Wackenbut J, and Glatstein E. Local control of Ewing’ s sarcoma of bone with radiotherapy and combination chemotherapy, Cancer, 46 (1980) 1965–1973.
Marcus RB, and Million RR. The effect of primary tumor size on the prognosis of Ewing’s sarcoma, Int. J. Radiat. Oncol. Biol. Phys., 10 (Suppl 1) (1994) 88.
Bacci G, Picci P, Gitelis S, Borghi A, and Campanacci M. The treatment of localized Ewing’s sarcoma. The experience at the Instituo Ortopedico Rizzoli in 163 cases treated with and without adjuvant chemotherapy, Cancer, 49 (1982) 1561–1570.
Jurgens H, Exner U, Gadner H, et al. Multidisciplinary treatment of primary Ewing’s sarcoma of bone. A 6-year experience of a European Cooperative Trial, Cancer, 61 (1988) 23–32.
Sailder SL, Harmon DC, Mankin HJ, Truman JT, and Suit HD. Ewing’ s sarcoma: surgical resection as a prognostic factor, Int. J. Radiat. Oncol. Biol. Phys., 15 (1988) 43–52.
Evans R, Nesbit M, Gehan E, Garnsey L, et al. Multimodal therapy for the management of localized Ewing’s sarcoma of pelvic and sacral bones: a report from the second intergroup study, J. Clin. Oncol., 9 (1991) 1173–1180.
Kronholz K, Prott FJ, Anders C, and Willich N. Flabs zur intraoperativen Bestrahlung. Medizinische Physik. Hrsg: H. Leitner, G. Stücklshweiger, S. 1996, pp. 39–40.
Enneking WF. A system of staging musculoskeletal neoplasms, Ballieere ‘s Clinical Oncology, 1 (1987) 97–110.
Brant T, Parsons J, Marcus R, Spanier S, Heare T, et al. Preoperative irradiation for soft tissue sarcomas of the trunk and extremities in adults, Int. J. Radiat. Oncol. Biol. Phys., 19 (1990) 899–906.
Kinsella TJ, Sindelar WF, and De Luca AM. Threshold dose for peripheral nerve injury following intraoperative radiotherapy (IORT) in a large animal model, Int. J. Radiat. Oncol. Biol. Phys.,15 (Suppl 1) 205.
Powers BE, Gillette EL, Mcchesney SL, et al. Muscle injury following experimental intraoperative irradiation, Int. J. Radiat. Oncol. Biol. Phys., 17 (Suppl 1) (1989) 246.
Gillete EL, Powers BE, Mcchesney SL, et al. Response of aorta and branch arteries to experimental intraoperative irradiation, Int. J. Radiat. Oncol. Biol. Phys., 15 (suppl 1) (1988) 202.
Powers BE, Gillette EL, Mcchesney SL, et al. Bone necrosis and tumor induction following experimen- tal intraoperative irradiation, Int. J. Radiat. Oncol. Biol. Phys., 17 (1989) 559–567.
Le Coteur RA, Gillette EL, Powers BE, et al. Peripheral neuropathies following experimental intraoperative radiation therapy (IORT), Int. J. Radiat. Oncol. Biol. Phys., 11 (1989) 1579–1585.
Kinsella TJ, Sindelar WF, De Luca AM, Tolerance of peripheral nerve to intraoperative radiotherapy (IORT): clinical and experimental studies, Int. J. Radiat. Oncol. Biol. Phys.,11 (1985) 15791585.
Powers BE, Gillette EL, Mcchesney SL, et al. Bone necrosis and tumor induction following experimental intraoperative irradiation, Int. J. Radiat. Oncol. Biol. Phys., 17 (1989) 559–567.
Rosen G, Caparros B, Nirenberg A, Marcove RC, Huvos AG, Kosloff C, Lane J, and Murphy ML. Ewing’s sarcoma. Ten-years experience with adjuvant chemotherapy, Cancer, 47 (1981) 2204–2213.
Eilber F, Giuliano A, Edkardt J, Patterson K, Moseley S, and Goonight J. Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial, J. Clin. Oncol., 5 (1987) 21–26.
Bacci G, Springfield D, Capnna R, et al. Neoadjuvant chemotherapy for osteosarcoma of the extremity, Clin. Orthop., 224 (1987) 268–276.
Wong ACW, Akahoshi Y, Takeuchi S. Limb-salvage procedures of osteosarcoma: an alternative to amputation, Int. Orthop., 10 (1986) 245–251.
Sugimoto M, Togochida J, Kotoura Y, Yamamuro T, and Utsumi H. In vitro radiosensitivity of osteosarcoma lines, Strahlenther. Onkol., 165 (1989) 782.
Poppe E, Liverud K, and Efskind. Osteosarcoma, Acta Chir. Scand., 134 (1968) 549–556.
Allen CF and Stevens KR. Preoperative irradiation for osteogenic sarcoma, Cancer,31 (1973) 13641366.
Jenkin RDT, Allt WEC, and Fitzpatrik PJ. Osteosarcoma: an assessment of management with particular reference to primary irradiation and selective delayed amputation, Cancer, 30 (1972) 393–400.
Philips TL and Sheline GE. Radiation therapy of malignant bone tumors, Radiology,92 (1969) 15371545.
Chambers RG and Mahoney WD. Osteogenic sarcoma of the mandible: current management, Am. Surg. 36 (1970) 463–471.
Suit HD. Radiotherapy in osteosarcoma, Clin. Orthop., 111 (1975) 71–75.
Breur K, Cohen P, Schweisguth O, and Amm H. Irradiation of the lungs or an adjuvant therapy in the treatment of osteosarcoma of the limbs. An EORTC randomized study, Eur. J. Cancer, 14 (1978) 461–471.
Burgers JM, van Glabbeke M, Bussan A, et al. Osteosarcoma of the limbs. Report of the EORTC-SIOP 03 trial 20781 investigating the value of adjuvant treatment with chemotherapy and/or prophylactic lung irradiation, Cancer, 61 (1988) 1024–1031.
Farrell C and Raventos A. Experiences in treating osteosarcoma at the hospital of the University of Pennsylvania, Radiology, 83 (1964) 1080–1083.
Cavaliere R. Hyperthermic treatment of osteogenic sarcoma, Chemoter. Oncol., 2 (1978) 190–196.
Abe M, Takahashi M, Shibamoto Y, and Ono K. Application of intraoperative radiation therapy to refractory cancers, Ann. Radiol., 32 (1989) 493–194.
Nagashima T, Yamamuro T, Kotoura Y, Takahashi M, and Abe M. Histological studies of the effect of intraoperative irradiation on osteosarcoma, Nippon Seikeigeka Gakkai Zasshi, 57 (1983) 1681–1697.
Yamamuro T, Kotoura Y, Kasahara K, Tadahashi M, and Abe M. Intraoperative radiotherapy for osteosarcoma, Strahlecther. Onkol., 165 (1989) 783.
Abe M, Takahashi M, Shibamoto Y, Ono K, Yabumoto E, and Mori K. Derzeitige Stellung der intraoperativen Strahlentherapie, Chirurg., 59 (1988) 211–217.
Kotoura Y, Yamamuro T, Kasahara K, Shibamoto Y, Takahashi M, and Abe M. Intraoperative radiation therapy for malignant bone tumors. In FW Schildberg, N Willich, and HJ Krämling (eds.) Intraoperative Radiation Therapy, Die Blane Eule, Essen, 1993, pp. 456–458.
Rosenberg SA, Tepper JE, Glastein EJ, et al. The treatment of soft tissue sarcomas of the extremities. Prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy, Ann. Surg. 196 (1982) 305–314.
Feldman F and Norman D. Intra and extraosseus malignant hi stiocytomas (malignant fibrous xanthoma) of bone, Radiology, 104 (1972) 97–108.
Campana R, Bertoni F, Baccini P, Bacci G, Gerra A, and Camapanacci M. Malignant fibrous histicytoma of bone. The experience at the Rizzoli Institute: report of 90 cases, Cancer, 54 (1984) 177–187.
Spanier SS, Enneking WF, and Enriquez P. Primary malignant fibrous histiocytoma of bone, Cancer, 36 (1975) 2084–2098.
Bacci G, Avella M, Picc I et al. The effectiveness of chemotherapy in localized malignant fibrous histiocytoma of bone: the Rizzoli Institute Experience with 66 patients treated with surgery alone or surgery + adjuvant or neoadjuvant chemotherapy, Chemioterapie, 7 (1989) 481–494.
Castillo I, Calvo FA, Aristu J, et al. Tratamiento intensive de sarcomas óseos de histología miscelânea: histiocitoma fibroso maligno y condrosarcoma, Oncología, 15 (1992) 351–358.
Stea et al. 1987.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Calvo, F.A., Sierrasesumaga, L., Willich, N., Amillo, S., Cañadell, J. (1999). IORT for Bone Sarcomas. In: Gunderson, L.L., Willet, C.G., Harrison, L.B., Calvo, F.A. (eds) Intraoperative Irradiation. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-696-6_21
Download citation
DOI: https://doi.org/10.1007/978-1-59259-696-6_21
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-5576-3
Online ISBN: 978-1-59259-696-6
eBook Packages: Springer Book Archive